Somatus Raises $325M To Deliver Proven Value-Based Kidney Care Model To More Americans With Kidney Disease

Feb 23, 2022•almost 4 years ago

Amount Raised

$325 Million

Description

Somatus, the nation’s leading and largest value-based kidney care company, today announced an oversubscribed Series E financing of $325+ million, at a valuation of over $2.5 billion. The funding will be used to further the reach and impact of its value-based kidney care model. Somatus’ model cares for the whole person by actively partnering with locally-based providers and bringing personalized, in-home care and support directly to patients with kidney disease.

Company Information

Company

Somatus

About

Somatus partners with leading nephrology and primary care groups, health plans, and health systems to provide integrated care for patients with, or at risk of developing, kidney disease. As the market leader in value-based kidney care, Somatus' vertically integrated clinical services and technology delay or prevent disease progression, improve quality and care coordination, and increase the use of home dialysis modalities and rates of kidney transplantation. The company is headquartered in McLean, Virginia, and founded by a team of world-class healthcare operators, successful entrepreneurs, and leading clinicians treating kidney disease. For more information, please visit www.somatus.com.

Related People

1 contact

Funding Insights

Based on industry data

Tech investment trends

83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech

Somatus Raises $325M To Deliver Proven Value-Based Kidney Care Model To More Americans With Kidney Disease

Description

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

Related People

Funding Insights

Company Information